Market Research

Antibody Production Market

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 175 Pages Transparency Market Research Pvt. Ltd. July, 2023 TNPR18164196
Best Price Guarantee
Price from $5,795
Length 175 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date July, 2023
SKU TNPR18164196

Antibody Production Market (Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Others; and Process: Upstream Processing, Downstream Processing, and Filtration) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Antibody Production Market – Scope of Report

TMR’s report on the global antibody production market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global antibody production market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global antibody production market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the antibody production market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global antibody production market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global antibody production market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global antibody production market.

The report delves into the competitive landscape of the global antibody production market. Key players operating in the global antibody production market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global antibody production market profiled in this report.

Key Questions Answered in Global Antibody Production Market Report
  • What is the sales/revenue generated by antibody production across all regions during the forecast period?
  • What are the opportunities in the global antibody production market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Antibody Production Market – Research Objectives and Research Approach

The comprehensive report on the global antibody production market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global antibody production market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global antibody production market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Antibody Production Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Antibody Production Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Technological Advancements
5.2. Key Mergers & Acquisitions
5.3. Key Product/Brand Analysis
5.4. Top 3 Players Operating in Market Space
5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)
6. Global Antibody Production Market Analysis and Forecast, by Antibody Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Antibody Type, 2017-2031
6.3.1. Monoclonal Antibodies
6.3.2. Polyclonal Antibodies
6.3.3. Other Antibody Types
6.4. Market Attractiveness Analysis, by Antibody Type
7. Global Antibody Production Market Analysis and Forecast, by Process
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Process, 2017-2031
7.3.1. Upstream Processing
7.3.1.1. Bioreactors
7.3.1.1.1. Large-scale Bioreactors
7.3.1.1.2. Single-use Bioreactors
7.3.1.2. Consumables
7.3.2. Downstream Processing
7.3.2.1. Chromatography Systems
7.3.2.2. Chromatography Resins
7.3.3. Filtration
7.3.3.1. Filtration Systems
7.3.3.2. Filtration Consumables & Accessories
7.4. Market Attractiveness Analysis, by Process
8. Global Antibody Production Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Pharmaceutical and Biotechnology Companies
8.3.2. Research Laboratories
8.3.3. Other End-users
8.4. Market Attractiveness Analysis, by End-user
9. Global Antibody Production Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Antibody Production Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Antibody Type, 2017-2031
10.2.1. Monoclonal Antibodies
10.2.2. Polyclonal Antibodies
10.2.3. Other Antibody Types
10.3. Market Value Forecast, by Process, 2017-2031
10.3.1. Upstream Processing
10.3.1.1. Bioreactors
10.3.1.1.1. Large-scale Bioreactors
10.3.1.1.2. Single-use Bioreactors
10.3.1.2. Consumables
10.3.2. Downstream Processing
10.3.2.1. Chromatography Systems
10.3.2.2. Chromatography Resins
10.3.3. Filtration
10.3.3.1. Filtration Systems
10.3.3.2. Filtration Consumables & Accessories
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. Research Laboratories
10.4.3. Other End-users
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Antibody Type
10.6.2. By Process
10.6.3. By End-user
10.6.4. By Country
11. Europe Antibody Production Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Antibody Type, 2017-2031
11.2.1. Monoclonal Antibodies
11.2.2. Polyclonal Antibodies
11.2.3. Other Antibody Types
11.3. Market Value Forecast, by Process, 2017-2031
11.3.1. Upstream Processing
11.3.1.1. Bioreactors
11.3.1.1.1. Large-scale Bioreactors
11.3.1.1.2. Single-use Bioreactors
11.3.1.2. Consumables
11.3.2. Downstream Processing
11.3.2.1. Chromatography Systems
11.3.2.2. Chromatography Resins
11.3.3. Filtration
11.3.3.1. Filtration Systems
11.3.3.2. Filtration Consumables & Accessories
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. Research Laboratories
11.4.3. Other End-users
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Antibody Type
11.6.2. By Process
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Antibody Production Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Antibody Type, 2017-2031
12.2.1. Monoclonal Antibodies
12.2.2. Polyclonal Antibodies
12.2.3. Other Antibody Types
12.3. Market Value Forecast, by Process, 2017-2031
12.3.1. Upstream Processing
12.3.1.1. Bioreactors
12.3.1.1.1. Large-scale Bioreactors
12.3.1.1.2. Single-use Bioreactors
12.3.1.2. Consumables
12.3.2. Downstream Processing
12.3.2.1. Chromatography Systems
12.3.2.2. Chromatography Resins
12.3.3. Filtration
12.3.3.1. Filtration Systems
12.3.3.2. Filtration Consumables & Accessories
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. Research Laboratories
12.4.3. Other End-users
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Antibody Type
12.6.2. By Process
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Antibody Production Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Antibody Type, 2017-2031
13.2.1. Monoclonal Antibodies
13.2.2. Polyclonal Antibodies
13.2.3. Other Antibody Types
13.3. Market Value Forecast, by Process, 2017-2031
13.3.1. Upstream Processing
13.3.1.1. Bioreactors
13.3.1.1.1. Large-scale Bioreactors
13.3.1.1.2. Single-use Bioreactors
13.3.1.2. Consumables
13.3.2. Downstream Processing
13.3.2.1. Chromatography Systems
13.3.2.2. Chromatography Resins
13.3.3. Filtration
13.3.3.1. Filtration Systems
13.3.3.2. Filtration Consumables & Accessories
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. Research Laboratories
13.4.3. Other End-users
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Antibody Type
13.6.2. By Process
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Antibody Production Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Antibody Type, 2017-2031
14.2.1. Monoclonal Antibodies
14.2.2. Polyclonal Antibodies
14.2.3. Other Antibody Types
14.3. Market Value Forecast, by Process, 2017-2031
14.3.1. Upstream Processing
14.3.1.1. Bioreactors
14.3.1.1.1. Large-scale Bioreactors
14.3.1.1.2. Single-use Bioreactors
14.3.1.2. Consumables
14.3.2. Downstream Processing
14.3.2.1. Chromatography Systems
14.3.2.2. Chromatography Resins
14.3.3. Filtration
14.3.3.1. Filtration Systems
14.3.3.2. Filtration Consumables & Accessories
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Pharmaceutical and Biotechnology Companies
14.4.2. Research Laboratories
14.4.3. Other End-users
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Antibody Type
14.6.2. By Process
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Danaher Corporation
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Merck KGaA
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Sartorius
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Thermo Fisher Scientific Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Eppendorf AG
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. INTEGRA Biosciences AG
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Genetix Biotech Asia Pvt Ltd
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Solaris Biotech
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Grifols
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. F. Hoffmann-La Roche AG
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. FiberCell Systems Inc.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings